Kazumasa Ohtake

Title: Kazumasa Ohtake: Innovator in Antibody Technology

Introduction

Kazumasa Ohtake is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents to his name, Ohtake's work is recognized for its innovative approach to antibody engineering.

Latest Patents

Ohtake's latest patents focus on antibodies with non-natural amino acids introduced into their structure. One of his inventions relates to a monoclonal antibody or antibody fragment that includes at least one lysine derivative in the constant region of a human IgG antibody. This invention encompasses a modified antibody or antibody fragment, a nucleic acid encoding the antibody, a vector containing the nucleic acid, and a transformed cell obtained by introducing the vector into a host cell. Additionally, he has developed methods for producing these antibodies and compositions containing them.

Career Highlights

Throughout his career, Kazumasa Ohtake has worked with notable companies such as Riken Corporation and Kyowa Kirin Co., Ltd. His experience in these organizations has allowed him to refine his expertise in antibody research and development.

Collaborations

Ohtake has collaborated with esteemed colleagues, including Kensaku Sakamoto and Yoshimi Yamaguchi. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Kazumasa Ohtake's innovative work in antibody technology highlights his significant role in the biotechnology field. His contributions continue to influence advancements in medical research and therapeutic applications.